Therapeutics News and Research

RSS

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.

17 Nov 2016

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics.

17 Nov 2016

Global effort may help win battle against antibiotic resistance

Antimicrobial resistance (AMR) does not seem to cause much worry among the general population and can be thought of as a future problem.

17 Nov 2016

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer.

17 Nov 2016

Mapi, Saama Technologies team up to strengthen analytics enabled business outcomes for customers

Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.

16 Nov 2016

Enterome, Bristol-Myers Squibb enter into Immuno-Oncology collaboration to identify new microbiome-derived biomarkers for cancer

Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.

16 Nov 2016

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab).

16 Nov 2016

Photoimmunotherapy may be promising treatment option to combat cancer

When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel.

15 Nov 2016

Genetically engineered bacteria designed with thermostat controls may help treat diseases

A new helper in the fight against cancer and other diseases of the gut may be genetically altered bacteria that release medicines to tumors or the gut.

15 Nov 2016

NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone's Perlmutter Cancer Center, has received a 2016 "Giants of Cancer Care" Award.

14 Nov 2016

Study shows how Zika virus infection leads to production of smaller disease-causing RNAs

Researchers, led by scientists at the University of Colorado School of Medicine, have found basic molecular processes used by the Zika virus to "hijack" the cells that it infects and potentially how it makes molecules that are directly linked to disease.

11 Nov 2016

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.

11 Nov 2016

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

10 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

Novel purification process for camelid heavy chain antibodies

KNAUER Wissenschaftliche Geräte GmbH and 3B Pharmaceuticals GmbH today announced the successful completion of a federal grant program exploiting the potential of camelid antibodies.

From KNAUER Wissenschaftliche Geräte GmbH 9 Nov 2016

Marker found on aggressive prostate cancer cells could help guide treatments, new research shows

RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.

9 Nov 2016

Collapse of MAM is common pathological hallmark to certain inherited forms of ALS

Amyotrophic lateral sclerosis (ALS) is an adult onset, fetal neurodegenerative disease that selectively affects motor neurons.

8 Nov 2016

Gas-filled balloon capsules provide new low risk treatment option for patients with obesity

Patients with obesity who swallowed gas-filled balloon capsules designed to help them eat less, lost 1.9 times more weight than patients who relied on diet, exercise and lifestyle therapy alone, according to new research presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity.

7 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Therapeutics News and Research

Researchers identify pathway that helps cancer cells to aggressively spread in the brain

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

Global effort may help win battle against antibiotic resistance

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

Mapi, Saama Technologies team up to strengthen analytics enabled business outcomes for customers

Enterome, Bristol-Myers Squibb enter into Immuno-Oncology collaboration to identify new microbiome-derived biomarkers for cancer

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Photoimmunotherapy may be promising treatment option to combat cancer

Genetically engineered bacteria designed with thermostat controls may help treat diseases

NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

Study shows how Zika virus infection leads to production of smaller disease-causing RNAs

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Investigational treatment combination improves virologic control in SIV-infected monkeys

Novel purification process for camelid heavy chain antibodies

Marker found on aggressive prostate cancer cells could help guide treatments, new research shows

Collapse of MAM is common pathological hallmark to certain inherited forms of ALS

Gas-filled balloon capsules provide new low risk treatment option for patients with obesity

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Understanding the DNA Damage Response in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News